Marc Duey Aprea Therapeutics, Inc. (APRE) insider trading activity

Marc Duey is Director of Aprea Therapeutics, Inc.. Currently has a direct ownership of 256,155 shares of APRE, which is worth approximately $309,947. The most recent transaction as insider was on Dec 10, 2025, when has been sold 21,459 shares (Common Stock) at a price of $1.17 per share, resulting in proceeds of $25,107. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 256K

9.14% 3M change

9.63% 12M change

Total Value Held $309,947

Marc Duey Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 10 2025	BUY Open market or private purchase	$25,107 $1.17 p/Share	21,459 Added 7.73%	256,155 Common Stock
Jun 05 2025	BUY Grant, award, or other acquisition	-	1,045 Added 0.44%	234,696 Common Stock
Oct 18 2024	SELL Open market or private sale	$29,595 $4.58 p/Share	6,462 Reduced 2.69%	233,651 Common Stock
Oct 16 2024	BUY Open market or private purchase	$131,700 $4.39 p/Share	30,000 Added 11.11%	240,113 Common Stock
Oct 14 2024	BUY Open market or private purchase	$490 $2.58 p/Share	190 Added 0.09%	210,113 Common Stock
Jun 20 2024	BUY Grant, award, or other acquisition	-	1,045 Added 0.5%	209,923 Common Stock
Aug 23 2023	BUY Grant, award, or other acquisition	-	500 Added 0.24%	208,878 Common Stock

Aug 23 2022	BUY Conversion of derivative security	-	4,009,690 Added 49.03%	4,167,589 Common Stock
Jul 28 2022	BUY Grant, award, or other acquisition	-	5,995 Added 3.66%	157,899 Common Stock

Marc Duey

Director

Boston, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells APRE shares.

Notify only if

Value

Insider Trading

Get notified when an Aprea Therapeutics, Inc. insider buys or sells APRE shares.

Notify only if

Operation

Value

Type

News

Receive news related to Aprea Therapeutics, Inc.

Track Activities on APRE

Account